Search research articles
Contact Us
Filters
Showing results (141-150 of 150) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 150 results.
Breast (Edinburgh, Scotland)
|
July 19, 2016
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer
D Andreis, S Bonardi, G Allevi, et al.
Journal of Endocrinological Investigation
|
June 10, 2024
Changes in body composition in early breast cancer patients treated with aromatase inhibitors
R Pedersini, G Schivardi, L Laini, et al.
Endocrine
|
November 8, 2017
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience
G Mazziotti, A M Formenti, M B Panarotto, et al.
Bone
|
April 26, 2026
Multiparametric assessment of bone health in metastatic hormone-sensitive prostate cancer patients receiving androgen deprivation + enzalutamide ± zoledronic acid (BonEnza study)
I Caramella, A Dalla Volta, F Valcamonico, et al.
ESMO Open
|
August 9, 2024
TRAbectedin in adVanced rEtroperitoneal well differentiated/dedifferentiated Liposarcoma and Leiomyosarcoma (TRAVELL): results of a phase II study from the Italian Sarcoma Group
C Fabbroni, G Grignani, B Vincenzi, et al.
British Journal of Cancer
|
December 3, 2014
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer
L Bazzola, C Foroni, D Andreis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 23, 2015
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study
R Libé, I Borget, C L Ronchi, et al.
European Journal of Endocrinology
|
October 28, 2021
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study
Y S Elhassan, B Altieri, S Berhane, et al.
ESMO Open
|
March 11, 2026
Current clinical management and outcome of patients with adrenal cortical carcinoma (ACC) with rare histological subtypes-an ENSAT cohort study
O Kimpel, D Cosentini, A Calabrese, et al.
ESMO Open
|
November 12, 2025
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)
F Spada, F Gelsomino, M Rinzivillo, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 150) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 150 results.
Breast (Edinburgh, Scotland)
|
July 19, 2016
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer
D Andreis, S Bonardi, G Allevi, et al.
Journal of Endocrinological Investigation
|
June 10, 2024
Changes in body composition in early breast cancer patients treated with aromatase inhibitors
R Pedersini, G Schivardi, L Laini, et al.
Endocrine
|
November 8, 2017
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience
G Mazziotti, A M Formenti, M B Panarotto, et al.
Bone
|
April 26, 2026
Multiparametric assessment of bone health in metastatic hormone-sensitive prostate cancer patients receiving androgen deprivation + enzalutamide ± zoledronic acid (BonEnza study)
I Caramella, A Dalla Volta, F Valcamonico, et al.
ESMO Open
|
August 9, 2024
TRAbectedin in adVanced rEtroperitoneal well differentiated/dedifferentiated Liposarcoma and Leiomyosarcoma (TRAVELL): results of a phase II study from the Italian Sarcoma Group
C Fabbroni, G Grignani, B Vincenzi, et al.
British Journal of Cancer
|
December 3, 2014
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer
L Bazzola, C Foroni, D Andreis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 23, 2015
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study
R Libé, I Borget, C L Ronchi, et al.
European Journal of Endocrinology
|
October 28, 2021
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study
Y S Elhassan, B Altieri, S Berhane, et al.
ESMO Open
|
March 11, 2026
Current clinical management and outcome of patients with adrenal cortical carcinoma (ACC) with rare histological subtypes-an ENSAT cohort study
O Kimpel, D Cosentini, A Calabrese, et al.
ESMO Open
|
November 12, 2025
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)
F Spada, F Gelsomino, M Rinzivillo, et al.
Page
of 15